SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-09-000037
Filing Date
2009-05-15
Accepted
2009-05-15 16:38:57
Documents
5
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10-q.htm 10-Q 534115
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-1 exhibit31-1.htm EX-31.1 16038
3 CERTIFICATION OF ACTING PRINCIPAL ACCOUNING OFFICER PURSUANT TO RULE 13A-14(A) O exhibit31-2.htm EX-31.2 16342
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 AS ADOPT exhibit32-1.htm EX-32.1 6524
5 CERTIFICATION OF ACTING PRINCIPAL ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. 1350 exhibit32-2.htm EX-32.2 6393
  Complete submission text file 0001424884-09-000037.txt   580992
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 09833814
SIC: 2834 Pharmaceutical Preparations